|
SOCS5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.591500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.951600E-01 |
| Normal-vs-Stage2 |
1.381830E-01 |
| Normal-vs-Stage3 |
4.463600E-02 |
| Normal-vs-Stage4 |
4.814700E-04 |
| Stage1-vs-Stage2 |
2.492600E-01 |
| Stage1-vs-Stage3 |
8.282400E-02 |
| Stage1-vs-Stage4 |
7.399000E-04 |
| Stage2-vs-Stage3 |
9.264200E-01 |
| Stage2-vs-Stage4 |
2.633000E-01 |
| Stage3-vs-Stage4 |
7.133600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.135010E-01 |
| Normal-vs-AfricanAmerican |
1.821570E-02 |
| Normal-vs-Asian |
4.787600E-01 |
| Caucasian-vs-AfricanAmerican |
1.112430E-01 |
| Caucasian-vs-Asian |
9.007200E-01 |
| AfricanAmerican-vs-Asian |
6.525600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.844400E-02 |
| Normal-vs-Female |
1.474010E-01 |
| Male-vs-Female |
6.084400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.464980E-01 |
| Normal-vs-Age(41-60Yrs) |
2.367800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.928100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.584400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.982000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.708000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.548400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.556800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.286430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.281000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.443400E-01 |
| Normal-vs-Grade 2 |
7.994200E-01 |
| Normal-vs-Grade 3 |
9.559500E-03 |
| Normal-vs-Grade 4 |
4.247200E-04 |
| Grade 1-vs-Grade 2 |
3.175000E-01 |
| Grade 1-vs-Grade 3 |
1.947570E-02 |
| Grade 1-vs-Grade 4 |
3.717900E-03 |
| Grade 2-vs-Grade 3 |
2.663400E-03 |
| Grade 2-vs-Grade 4 |
2.780500E-04 |
| Grade 3-vs-Grade 4 |
6.520000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.906800E-01 |
| Normal-vs-ccB subtype |
6.348100E-02 |
| ccA subtype-vs-ccB subtype |
1.335220E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.763230E-01 |
| Normal-vs-N1 |
4.771800E-02 |
| N0-vs-N1 |
2.248200E-01 |
|
|
